Reference
Rubio LMH, et al. Mevalonate kinase secondary cardiomyopathy: Nonrecognized complication or pharmacological adverse reaction?. Advances in Rheumatology 58 (Suppl. 1): 76 abstr. P280, 2018. Available from: URL: http://doi.org/10.1186/s42358-018-0019-7 [abstract] - Colombia
Rights and permissions
About this article
Cite this article
Anakinra. Reactions Weekly 1728, 41 (2018). https://doi.org/10.1007/s40278-018-54304-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-54304-7